Targeting GLP-1R & GIPR in a Novel Biospecific Mechanism to Advance a Longer-Acting Therapy for Weight-Loss
Time: 9:30 am
day: Conference Day 1
Details:
- Synergistic effects on weight loss and metabolic parameters in preclinical obese models
- Balancing durability, efficacy and safety to attain significant reduction in body weight
- Demonstrating competitive advantage with a first-in-class mechanism in Phase 1 and beyond and advancing a Phase 2 dose-ranging trials to demonstrate significant and durable weight loss
